We are live on ! Find out more
CLOS

Compagnie Lombard Odier SCmA Portfolio holdings

AUM $9.25B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$3.74B
AUM Growth
+$267M
Cap. Flow
+$37.4M
Cap. Flow %
1%
Top 10 Hldgs %
40.57%
Holding
729
New
113
Increased
159
Reduced
117
Closed
50

Top Buys

Rank Stock Value
1
BN icon
Brookfield
BN
+$19M
2
UNH icon
UnitedHealth
UNH
+$18.8M
3
BEKE icon
KE Holdings
BEKE
+$10.6M
4
KEYS icon
Keysight
KEYS
+$8.63M
5
PG icon
Procter & Gamble
PG
+$8.49M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$25.9M
2
HON icon
Honeywell
HON
+$23.8M
3
SPGI icon
S&P Global
SPGI
+$9.56M
4
V icon
Visa
V
+$9.36M
5
IQV icon
IQVIA
IQV
+$7.39M

Sector Composition

Rank Sector Weight
1 Technology 22%
2 Financials 17.21%
3 Healthcare 15.91%
4 Communication Services 12.4%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETN icon
426
Eaton
ETN
$180B
$74K ﹤0.01%
470
-3,141
-87% -$482K
REET icon
427
iShares Global REIT ETF
REET
$5.01B
$74K ﹤0.01%
3,226
-1,459
-31% -$32.5K
RIVN icon
428
Rivian
RIVN
$23.6B
$74K ﹤0.01%
4,040
– –
IXC icon
429
iShares Global Energy ETF
IXC
$2.74B
$73K ﹤0.01%
1,867
– –
SE icon
430
Sea Limited
SE
$78.5B
$73K ﹤0.01%
1,400
– –
PROK icon
431
ProKidney
PROK
$324M
$72K ﹤0.01%
10,500
– –
RUN icon
432
Sunrun
RUN
$2.44B
$72K ﹤0.01%
+3,000
New +$80.1K
IBRX icon
433
ImmunityBio
IBRX
$7.99B
$71K ﹤0.01%
14,000
– –
ROKU icon
434
Roku
ROKU
$22.5B
$71K ﹤0.01%
1,750
+250
+17% +$13.1K
VEEV icon
435
Veeva Systems
VEEV
$38.5B
$71K ﹤0.01%
+443
New +$75.7K
MTCH icon
436
Match Group
MTCH
$8.48B
$70K ﹤0.01%
1,695
+1,295
+324% +$58.5K
BKR icon
437
Baker Hughes
BKR
$64.1B
$69K ﹤0.01%
+2,336
New +$64.4K
HDRO
438
DELISTED
Defiance Next Gen H2 ETF
HDRO
$69K ﹤0.01%
919
– –
QLYS icon
439
Qualys
QLYS
$6.38B
$67K ﹤0.01%
600
– –
TDOC icon
440
Teladoc Health
TDOC
$1.28B
$67K ﹤0.01%
2,806
– –
IBB icon
441
iShares Biotechnology ETF
IBB
$9.79B
$66K ﹤0.01%
500
– –
PAYX icon
442
Paychex
PAYX
$43B
$66K ﹤0.01%
+570
New +$66.7K
TTWO icon
443
Take-Two Interactive
TTWO
$47.6B
$65K ﹤0.01%
623
+473
+315% +$51.2K
SYY icon
444
Sysco
SYY
$40B
$64K ﹤0.01%
+842
New +$68K
ARKW icon
445
ARK Web x.0 ETF
ARKW
$1.76B
$63K ﹤0.01%
1,642
– –
HPE icon
446
Hewlett Packard
HPE
$71.8B
$63K ﹤0.01%
+3,973
New +$58.6K
NDAQ icon
447
Nasdaq
NDAQ
$53.5B
$63K ﹤0.01%
+1,035
New +$64.5K
SPYD icon
448
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.69B
$63K ﹤0.01%
1,600
– –
VTRS icon
449
Viatris
VTRS
$18.7B
$63K ﹤0.01%
5,551
– –
IWB icon
450
iShares Russell 1000 ETF
IWB
$50.2B
$62K ﹤0.01%
+297
New +$62.9K
16 17
18
19 20

Similar funds

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $9.18B AUM 25.04% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Compagnie Lombard Odier SCmA's Q4 2022 Portfolio in Review

As of Q4 2022, Compagnie Lombard Odier SCmA held 729 positions worth $3.74B, up 7.7% from $3.47B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Compagnie Lombard Odier SCmA's Q4 2022 filing shows 113 new, 159 increased, 117 reduced and 50 closed positions. Its largest new stake was Brookfield: 848,850 shares worth $17.8M. The largest sale was Amgen, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Compagnie Lombard Odier SCmA's largest Q4 2022 buy was Brookfield: 848,850 shares worth $17.8M.
  • Compagnie Lombard Odier SCmA added most to UnitedHealth in Q4 2022, an estimated $18.8M increase.
  • Compagnie Lombard Odier SCmA's biggest Q4 2022 reduction was Amgen, cutting an estimated $25.9M.
  • Compagnie Lombard Odier SCmA fully exited Hyatt Hotels in Q4 2022, selling an estimated $988K.
  • Compagnie Lombard Odier SCmA's ten largest holdings make up 41% of its $3.74B portfolio in Q4 2022.
  • Compagnie Lombard Odier SCmA opened 113 new positions and closed 50 in Q4 2022.
  • Compagnie Lombard Odier SCmA's portfolio value rose 7.7% quarter-over-quarter to $3.74B.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2022, filed 13 Feb 2023.